Posterior mediastinal tumors

Pediatric Thoracic Surgery

Volumn , Issue , 2009, Pages 235-250

  Arul, G S ^a   Parikh, Dakshesh H ^a   Narayanaswamy, Bommayya ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77955672532     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/b136543_19     Document Type: Chapter

References (95)

1. Brodeur GM, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams and Wilkins, 2006:933-970.
2. Institute. NC. Surveillance, Epidemiology and End results database: http://seer.cancer.gov, 2005.
3. Adams GA, Shochat SJ, Smith EI, et al. Thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg 1993; 28: 372-377.
4. Haberle B, Hero B, Berthold F, von Schweinitz D. Characteristics and outcome of thoracic neuroblastoma. Eur J Pediatr Surg 2002; 12: 145-150.
5. Virchow R. Hyperplasie der Zirbel und der Nebennieren. In: Die Krankhaften Geschwulste. Vol 2. 1864-65.
6. Marchand F. Beitrage zur Kenntniss der normalen und pathologischen Anatomie der Glandula carotica und der Nebennieren. Festschrift fur Ruduloph. Vichows Arch. 1891; 5: 578.
7. Cushing H, Wolback SB. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuoma. Am J Pathol 1927; 3: 203.
8. Beckwith JB, Perrin EV. In situ neuroblastomas: A contribution to the natural history of neural crest tumors. Am J Pathol 1963; 43: 1089.
9. Everson TC, Cole WH. Spontaneous regression of neuroblastoma. In: Everson TC, Cole WH, eds. Spontaneous Regression of Cancer. Philadelphia, Pa: WB Saunders; 1966: 88.
10. Mason GA, Hart-Mercer J, Millar EJ, et al. Adrenaline-secreting neuroblastoma in an infant. Lancet 1957; 273(6990): 322-325.
11. Shimada H, Chatten J, Newton WA, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73: 405-416.
12. Schwab M, Alitalo K, Klempnauer KH, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 1983; 305: 245-248.
13. Stiller C, Quinn M, Rowan S. Childhood Cancer. In: Collingwood Bakeo A, Clarke L, editors. The Health of Children and Young People. London: National Statistics, 2001.
14. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nature Rev Cancer 2003; 3: 203-216.
15. Satge D, Sasco AJ, Carlsen NL, et al. A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res 1998; 58: 448-452.
16. Grimmer MR, Weiss WA. Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr 2006; 18: 634-638.
17. Beckwith JB, Martin RF. Observations on the histopathology of neuroblastomas. J Pediatr Surg 1968; 3:106-110.
18. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007; 369: 2106-2120.
19. Peuchmaur M, d'Amore ES, Joshi VV, et al. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma. Cancer 2003; 98: 2274-2281.
20. Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86: 364-372.
21. Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 1999; 86: 349-363.
22. Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 2003; 4: 472-480.
23. Strenger V, Kerbl R, Dornbusch HJ, et al. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer 2007; 48: 504-509.
24. McLatchie GR, Young DG. Presenting features of thoracic neuroblastoma. Arch Dis Child 1980; 55: 958-962.
25. Kang CH, Kim YT, Jeon SH, et al. Surgical treatment of malignant mediastinal neurogenic tumors in children. Eur J Cardiothorac Surg 2007; 31: 725-730.
26. Gupta H, Conrad J, Khoury JD, et al. Significance of pleural effusion in neuroblastoma. Pediatr Blood Cancer 2007; 49: 906-908.
27. Boglino C, Martins AG, Ciprandi G, et al. Spinal cord vascular injuries following surgery of advanced thoracic neuroblastoma: an unusual catastrophic complication. Med Ped Onc 1999; 32: 349-352.
28. Plantaz D, Rubie H, Michon J, et al. The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. A prospective study of 42 patients-results of the NBL 90 Study of the French Society of Pediatric Oncology. Cancer 1996; 78: 311-319.
29. Sandberg DI, Bilsky MH, Kushner BH, et al. Treatment of spinal involvement in neuroblastoma patients. Pediatr Neurosurg 2003; 39: 291-298.
30. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11: 1466-1477.
31. Cecchetto G, Mosseri V, De Bernardi B, et al. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 2005; 23: 8483-8489.
32. Evans AE, D'Angio GJ, Propert K, et al. Prognostic factors in neuroblastoma. Cancer 1987; 59: 1853-1859.
33. De Bernardi B, Pianca C, Boni L, et al. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma. Cancer 1992; 70: 1625-1633.
34. Suita S, Tajiri T, Higashi M, et al. Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan. Eur J Pediatr Surg 2007; 17: 23-28.
35. Conte M, Parodi S, De Bernardi B, et al. Neuroblastoma in adolescents: the Italian experience. Cancer 2006; 106: 1409-1417.
36. D'Angio GJ, Evans AE, Koop CE. Special pattern of widespread neuroblastoma with a favorable prognosis. Lancet 1971; 1(7708): 1046-1049.
37. Lacreuse I, Valla JS, de Lagausie P, et al. Thoracoscopic resection of neurogenic tumors in children. J Pediatr Surg 2007; 42: 1725-1728.
38. Cruccetti A, Kiely EM, Spitz L, et al. Pelvic neuroblastoma: low mortality and high morbidity. J Pediatr Surg 2000; 35: 724-728.
39. Suita S, Tajiri T, Sera Y, et al. The characteristics of mediastinal neuroblastoma. Eur J Pediatr Surg 2000; 10: 353-359.
40. Horiuchi A, Muraji T, Tsugawa C, et al. Thoracic neuroblastoma: outcome of incomplete resection. Pediatr Surg Int 2004; 20: 714-718.
41. Granata C, Fagnani AM, Gambini C, et al. Features and outcome of neuroblastoma detected before birth. J Pediatr Surg 2000; 35: 88-91.
42. Acharya S, Jayabose S, Kogan SJ, et al. Prenatally diagnosed neuroblastoma. Cancer 1997; 80: 304-310.
43. Suita S. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions. J Pediatr Surg 2002; 37: 949-954.
44. Suita S, Zaizen Y, Sera Y, et al. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan. J Pediatr Surg 1996; 31: 555-558.
45. Tsubono Y, Hisamichi S. A halt to neuroblastoma screening in Japan.[comment]. NEJM 2004; 350: 2010-2011.
46. Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol 2000; 18: 477-486.
47. Hsu LL, Evans AE, D'Angio GJ. Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate. Med Ped Onc 1996; 27: 521-528.
48. Boztug K, Kiely E, Roebuck DJ, et al. Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment. Pediatr Blood Cancer 2006; 46: 253-257.
49. Kiely E. A technique for excision of abdominal and pelvic neuroblastomas. Ann Royal Col Surg Engl 2007; 89: 342-348.
50. Kiely EM. The surgical challenge of neuroblastoma. J Pediatr Surg 1994; 29: 128-133.
51. Perez CA, Matthay KK, Atkinson JB, et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol 2000; 18: 18-26.
52. Kushner BH, Cheung NK, LaQuaglia MP, et al. International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. J Clin Oncol 1996; 14: 2174-2180.
53. Evans AE, Silber JH, Shpilsky A, D'Angio GJ. Successful management of lowstage neuroblastoma without adjuvant therapies: a comparison of two decades, 1972 through 1981 and 1982 through 1992, in a single institution. J Clin Oncol 1996; 14: 2504-2510.
54. Powis MR, Imeson JD, Holmes SJ et al. The effect of complete excision on stage III neuroblastoma: a report of the European Neuroblastoma Study Group. J Pediatr Surg 1996; 31: 516-519.
55. Haase GM, Atkinson JB, Stram DO, et al. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems. J Pediatr Surg 1995; 30: 289-294.
56. Castel V, Tovar JA, Costa E, et al. The role of surgery in stage IV neuroblastoma. J Pediatr Surg 2002; 37: 1574-1578.
57. La Quaglia MP, Kushner BH, Su W, et al. The impact of gross total resection on local control and survival in high-risk neuroblastoma. J Pediatr Surg 2004; 39: 412-417.
58. Cantos MF, Gerstle JT, Irwin MS, et al. Surgical challenges associated with intensive treatment protocols for high-risk neuroblastoma. J Pediatr Surg 2006; 41: 960-965.
59. Kuroda T, Saeki M, Honna T, et al. Clinical significance of intensive surgery with intraoperative radiation for advanced neuroblastoma: does it really make sense? J Pediatr Surg 2003; 38:1735-1738.
60. Adkins ES, Sawin R, Gerbing RB, et al. Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study. J Pediatr Surg 2004; 39: 931-936.
61. von Allmen D, Grupp S, Diller L, et al. Aggressive surgical therapy and radiotherapy for patients with high-risk neuroblastoma treated with rapid sequence tandem transplant. J Pediatr Surg 2005; 40: 936-941.
62. Flores RM, Su W, Lal D, et al. Extrapleural pneumonectomy in children. J Pediatr Surg 2006; 41: 1738-1742.
63. de Cou JM, Schlatter MG, Mitchell DS, Abrams RS. Primary thoracoscopic gross total resection of neuroblastoma. J Laparoend Adv Surg Tech Pt A 2005; 15: 470-473.
64. La Quaglia MP. Surgical management of neuroblastoma. Semin Pediatr Surg 2001; 10: 132-139.
65. Gupta A, Kumar A, Walters S, et al. Analysis of needle versus open biopsy for the diagnosis of advanced stage pediatric neuroblastoma. Pediatr Blood Cancer 2006; 47: 875-879.
66. Reid MM, Roald B. Central review of bone marrow biopsy specimens from patients with neuroblastoma. J Clin Path 1996; 49: 691-692.
67. Reid MM, Roald B. Adequacy of bone marrow trephine biopsy specimens in children. J Clin Path 1996; 49: 226-229.
68. Pranikoff T, Hirschl RB, Schnaufer L. Approach to cervicothoracic neuroblastomas via a trap-door incision. J Pediatr Surg 1995; 30: 546-548.
69. Dartevelle PG, Chapelier AR, Macchiarini P, et al. Anterior transcervical- thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105: 1025-1034.
70. Nazari S. Transcervical approach (Dartevelle technique) for resection of lung tumours invading the thoracic inlet, sparing the clavicle. J Thorac Cardiovasc Surg 1996; 112: 558-560.
71. Vanakesa T, Goldstraw P. Antero-superior approaches in the practice of thoracic surgery. Eur J Cardiothorac Surg 1999; 15: 774-780.
72. Sauvat F, Brisse H, Magdeleinat P, et al. The transmanubrial approach: A new operative approach to cervicothoracic Neuroblastoma in children. Surgery 2006; 139; 109-114.
73. Grunenwald D, Spaggiari L. Transmanubrial osteomuscular sparing approach to apical chest tumours. Ann Thorac Surg 1997; 63: 563-566.
74. Verbeke SJME, Knaepen PJ, Slooff WBM, et al. Transmanubrial osteomuscular sparing approach for sulcus superior tumours. Acta Chir Belg 2003; 103: 577-581.
75. Petty JK, Bensard DD, Partrick DA, et al. Resection of neurogenic tumors in children: is thoracoscopy superior to thoracotomy? J Am Coll Surg 2006; 203: 699-703.
76. Easa D, Balaraman V, Ash K, et al. Congenital chylothorax and mediastinal neuroblastoma. J Pediatr Surg 1991; 26: 96-98.
77. Das Gupta TK, Brasfield RD, Strong EW, Hajdu SI. Benign solitary Schwannomas (neurilemomas). Cancer 1969; 24: 355-366.
78. Coffin CM, Dehner LP. Soft tissue tumours. In: Stocker TJ, Dehner LP, editors. Pediatric Pathology. Philadelphia: J.B.Lippincott, 1992: 1091-1132.
79. Jee WH, Oh SN, McCauley T, et al. Extraaxial neurofibromas versus neurilemmomas: discrimination with MRI. AJR 2004; 183: 629-633.
80. Coffin CM, Dehner LP. Peripheral neurogenic tumors of the soft tissues in children and adolescents: a clinicopathologic study of 139 cases. Pediatr Pathol 1989; 9: 387-407.
81. Plon S, Malkin D. Childhood Cancer and Heredity. In: Pizzo PA, Poplack DG, editors. Priciples and practice of Pediatric oncology. Philadelphia: Lippincott, 2006:14-37.
82. Raffensperger J, Cohen R. Plexiform neurofibromas in childhood. J Pediatr Surg 1972; 7: 144-151.
83. Nelems B Neurogenic Tumors In: Pearson FG, Deslauriers J, Ginsberg RJ, editors. Thoracic Surgery. Churchill Livingston, London, 1995: 1475-1481.
84. Neville H, Corpron C, Blakely ML, Andrassy R. Pediatric neurofibrosarcoma. J Pediatr Surg 2003; 38: 343-346.
85. Grillo HC, et al. Combined approach to "dumbbell" intrathoracic and intraspinal neurogenic tumours. Ann Thorac Surg 1983; 36: 402.
86. Constantini S, Soffer D, Siegel T, Shalit MN. Paraganglioma of the thoracic spinal cord with cerebrospinal fluid metastasis. Spine 1989;14: 643-645.
87. Papsin BC, Freeman JL, Davis A, Bell RS. Transclavicular approach to the neck, thoracic inlet, and axilla. Arch Otolaryngol Head Neck Surg 1995; 121: 984-987.
88. Hann U, Geist-Barth B, Menon AK, et al. Aortico-pulmonary paraganglioma associated with bilateral carotid body tumors. Diagnostic presentation and clinical implications. J Cardiovasc Surg 2001; 42: 131-134.
89. Lack EE, Stillinger RA, Colvin DB, et al. Aortico-pulmonary paraganglioma: report of a case with ultrastructural study and review of the literature. Cancer 1979; 43: 269-278.
90. Olson JL, Salyer WR. Mediastinal paragangliomas (aortic body tumor): a report of four cases and a review of the literature. Cancer 1978; 41: 2405-2412.
91. Koch CA, Pacak K. Endocrine Tumors. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams & Wilkins, 2006: 1139-1171.
92. Ludwig AD, Feig DI, Brandt ML, et al. Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg 2007; 194: 792-796
93. Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann New York Acad Sci 2006; 1073: 30-37.
94. Walz MK, Alesina PF, Wenger FA, et al. Laparoscopic and retroperitoneoscopic treatment of pheochromocytomas and retroperitoneal paragangliomas: results of 161 tumors in 126 patients. World J Surg 2006; 30: 899-908.
95. Black CT, Haase GM. Neuroblastoma and other adrenal tumours. In: Carachi R, Azmy A, Grosfeld JL, editors. The surgery of childhood tumours. London: Arnold, 1999:163-177.